OxySure Therapeutics, Inc. - FORM 10-K - EX-10.11.6 - EXTENSION OF THIRD MORATORIUM ON PAYMENT AGREEMENT, - April 15, 2014

Attached files

file filename
10-K - ANNUAL REPORT - OxySure Therapeutics, Inc.f10k2013_oxysure.htm
EX-10.42(2) - PP AVIATION CORPORATION, TEAMING AGREEMEN - OxySure Therapeutics, Inc.f10k2013ex10xlii2_oxysure.htm
EX-10.1.10 - FIFTH AMENDMENT TO SECOND EMPLOYMENT AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10i10_oxysure.htm
EX-10.3.5 - SINACOLA COMMERCIAL PROPERTIES, LTD. LEASE AMENDMENT, DATED DECEMBER 31, 2013 - OxySure Therapeutics, Inc.f10k2013ex10iii5_oxysure.htm
EX-10.40 - ALPHA CAPITAL ANSTALT ET AL, SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xl_oxysure.htm
EX-10.42 - PP AVIATION CORPORATION, TEAMING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xlii_oxysure.htm
EX-14.1.1 - AS AMENDED CODE OF ETHICS - OxySure Therapeutics, Inc.f10k2013ex14i1_oxysure.htm
EX-31.2 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex31ii_oxysure.htm
EX-23.2 - CONSENT - OxySure Therapeutics, Inc.f10k2013ex23ii_oxysure.htm
EX-10.42(1) - PP AVIATION CORPORATION, TEAMING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xlii1_oxysure.htm
EX-10.1.11 - AS AMENDED SECOND EMPLOYMENT AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10i11_oxysure.htm
EX-31.1 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex31i_oxysure.htm
EX-10.3.6 - SINACOLA COMMERCIAL PROPERTIES, LTD. LETTER AGREEMENT, DATED DECEMBER 31, 2013 - OxySure Therapeutics, Inc.f10k2013ex10iii6_oxysure.htm
EX-10.11.5 - THIRD MORATORIUM ON PAYMENT AGREEMENT, VENCORE SOLUTIONS, LLC DATED AUGUST 2, 2013 - OxySure Therapeutics, Inc.f10k2013ex10xi5_oxysure.htm
EX-10.38 - WALL STREET BUY SELL HOLD CONSULTING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xxxviii_oxysure.htm
EX-32 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex32_oxysure.htm
EX-10.41 - ALPHA CAPITAL ANSTALT ET AL, FORM OF WARRANT ISSUED PURSUANT TO SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xli_oxysure.htm
EX-10.39 - CERTIFICATE OF DESIGNATION OF SERIES B CONVERTIBLE PREFERRED STOCK - OxySure Therapeutics, Inc.f10k2013ex10xxxix_oxysure.htm
Exhibit 10.11.6
 
Tue 2/18/2014 6:24 AM
 
Julian,
 
The Settlement Date of December 31, 2013 referenced in both the Third Payment Moratorium & Settlement Agreement dated July 29, 2013 and the Subscription Agreement dated November 1, 2013, each of which was executed by Oxysure Systems, Inc. and VenCore Solutions LLC, is hereby extended to April 1, 2014.
 
Jim Johnson
 
VenCore Solutions LLC dba Vencore Capital
 
Phone:   (360) 852-0633
 
Email:  jim@ven-core.com or jim@vencorecapital.com
 
Corporate Offices:
 
4500 SW Kruse Way, Suite 170
 
Lake Oswego, OR 97035
 

 

 

OxySure Therapeutics, Inc. Reports